References
- Luyster FS, Strollo PJ, Zee PC, et al. Sleep: a health imperative. Sleep [Internet]. 2012;35:727–734. Available from. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3353049&tool=pmcentrez&rendertype=abstract
- Hillman DR, Murphy AS, Pezzullo L. The economic cost of sleep disorders. Sleep. 2006;29:299–305.
- Deloitte Access Economics. Re-awakening Australia: the economic cost of sleep disorders in Australia, 2010 [Internet]. Deloitte Access Econ. Kingston; 2011. Available from: http://www.sleephealthfoundation.org.au/pdfs/news/Reawakening Australia.pdf.
- National Institutes of Health. The National Center on Sleep Disorders Research (NCSDR) [Internet]. [ cited 2017 Jan 1]. Available from: https://www.nhlbi.nih.gov/about/org/ncsdr/.
- Filtness AJ, Armstrong KA, Watson A, et al. Sleep-related vehicle crashes on low speed roads. Accid Anal Prev [Internet]. 2017;99:279–286. Available from. http://linkinghub.elsevier.com/retrieve/pii/S0001457516304407
- Herman J, Kafoa B, Wainiqolo I, et al. Driver sleepiness and risk of motor vehicle crash injuries: a population-based case control study in Fiji (TRIP 12). Injury [Internet]. 2014;45:586–591. Available from. DOI:10.1016/j.injury.2013.06.007
- Landrigan C, Rothschild J, Cronin J, et al. Effect of reducing interns’ work hours on serious medical errors in intensive care units. N Engl J Med. 2004;351:1838–1848.
- National Institutes of Health - National Center on Sleep Disorders Research. 2011. National Institutes of Health Sleep Disorders Research Plan. Available from: https://www.nhlbi.nih.gov/files/docs/resources/sleep/201101011NationalSleepDisordersResearchPlanDHHSPublication11-7820.pdf.
- Krystal AD, Benca RM, Kilduff TS. Understanding the sleep-wake cycle: sleep, insomnia, and the orexin system. J Clin Psychiatry. 2013;74:3–20.
- Kaplan RM. The mind reader: the forgotten life of Hans Berger, discoverer of the EEG. Australas. Psychiatry [Internet]. 2011 [cited 2013 May 29];19:168–169. Available from. http://www.ncbi.nlm.nih.gov/pubmed/21443395
- Iber C, Ancoli-Israel S, Quan SF. The AASM manual for the scoring of sleep and associated events: rules, terminology, and technical specification. 1st ed. Westchester, Illinois: American Academy of Sleep; 2007.
- Kales A, Hoedemaker FS, Jacobson A, et al. Mentation during sleep: REM and NREM recall reports. Percept Mot Skills. 1967;24:555–560.
- Dement W, Kleitman N. Cyclic variations in EEG during sleep and their relation to eye movements, body motility, and dreaming. Electroencephalogr Clin Neurophysiol [Internet]. 1957;9:673–690. Available from. http://www.ncbi.nlm.nih.gov/pubmed/13480240
- Saper CB, Chou TC, Scammell TE. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci. 2001;24:726–731.
- Moruzzi G, Magoun HW. Brain stem reticular formation and activation of the EEG. Electroencephalogr. Clin Neurophysiol [Internet]. 1949;1:455–473. Available from. http://www.ncbi.nlm.nih.gov/pubmed/18421835
- Yeo SS, Chang PH, Jang SH. The ascending reticular activating system from pontine reticular formation to the thalamus in the human brain. Front Hum Neurosci [Internet]. 2013;7:416. Available from. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3722571&tool=pmcentrez&rendertype=abstract
- Hur EE, Zaborszky L. Vglut2 afferents to the medial prefrontal and primary somatosensory cortices: a combined retrograde tracing in situ hybridization study [corrected]. J Comp Neurol [Internet]. 2005;483:351–373. Available from. http://www.ncbi.nlm.nih.gov/pubmed/15682395
- Fairén A. Cajal and Lorente de Nó on cortical interneurons: coincidences and progress. Brain Res Rev [Internet]. 2007;55:430–444. Available from. http://www.ncbi.nlm.nih.gov/pubmed/17659782
- Jones BE. Arousal systems. Front Biosci [Internet]. 2003;8:s438–51. Available from. http://www.ncbi.nlm.nih.gov/pubmed/12700104
- Chou TC, Bjorkum AA, Gaus SE, et al. Afferents to the ventrolateral preoptic nucleus. J Neurosci. 2002;22:977–990.
- Gallopin T, Fort P, Eggermann E, et al. Identification of sleep-promoting neurons in vitro. Nature [Internet]. 2000;404:992–995. Available from. http://www.nature.com/doifinder/10.1038/35010109
- De La Herrán-Arita AK, Zomosa-Signoret VC, Millán-Aldaco DA, et al. Aspects of the narcolepsy-cataplexy syndrome in O/E3-null mutant mice. Neuroscience [Internet]. 2011 cited 2012 Feb 10;183:134–143. Available from. http://www.ncbi.nlm.nih.gov/pubmed/21435382
- Peyron C, Tighe DK, Van Den Pol A, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci [Internet]. 1998;18:9996–10015. Available from. http://www.ncbi.nlm.nih.gov/pubmed/9822755
- De Lecea L, Kilduff T, Peyron C, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc [Internet]. 1998 cited 2012 Sep 19;95:322–327. Available from. http://www.pnas.org/content/95/1/322.short
- Lee MG, Hassani OK, Jones BE. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci [Internet]. 2005 [cited 2013 Oct 17];25:6716–6720. Available from. http://www.ncbi.nlm.nih.gov/pubmed/16014733
- Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron [Internet]. 2000;27:469–474. Available from. http://www.ncbi.nlm.nih.gov/pubmed/11055430
- Sherin JE, Elmquist JK, Torrealba F, et al. Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J Neurosci. 1998;18:4705–4721.
- Steininger TL, Gong H, McGinty D, et al. Subregional organization of preoptic area/anterior hypothalamic projections to arousal-related monoaminergic cell groups. J Comp Neurol [Internet]. 2001;429:638–653. Available from. http://www.ncbi.nlm.nih.gov/pubmed/11135241
- Suntsova N, Szymusiak R, Md. Alam N, et al. Sleep-waking discharge patterns of median preoptic nucleus neurons in rats. J Physiol [Internet]. 2002;543:665–677. Available from. /pmc/articles/PMC2290500/?report=abstract
- Rao Y, Lu M, Ge F, et al. Regulation of synaptic efficacy in hypocretin/orexin-containing neurons by melanin concentrating hormone in the lateral hypothalamus. J Neurosci [Internet]. 2008;28:9101–9110. Available from. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2562258&tool=pmcentrez&rendertype=abstract
- Verret L, Goutagny R, Fort P, et al. A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep. BMC Neurosci [Internet]. 2003;4:19. Available from. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=201018&tool=pmcentrez&rendertype=abstract
- Jouvet M. Research on the neural structures and responsible mechanisms in different phases of physiological sleep. Arch Ital Biol. 1962;100:125–206.
- Lu J, Sherman D, Devor M, et al. A putative flip-flop switch for control of REM sleep. Nature [Internet]. 2006 cited 2012 Jul 21;441:589–594. Available from. http://www.ncbi.nlm.nih.gov/pubmed/16688184
- Clement O, Sapin E, Libourel P-A, et al. The lateral hypothalamic area controls paradoxical (REM) sleep by means of descending projections to brainstem GABAergic neurons. J Neurosci [Internet]. 2012;32:16763–16774. Available from. http://www.jneurosci.org/cgi/doi/10.1523/JNEUROSCI.1885-12.2012
- Szymusiak R, Alam N, Steininger TL, et al. Sleep-waking discharge patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats. Brain Res. 1998;803:178–188.
- Krenzer M, Anaclet C, Vetrivelan R, et al. Brainstem and spinal cord circuitry regulating REM sleep and muscle atonia. Plos One [Internet]. 2011 cited 2012 Oct 9;6:e24998. Available from. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3197189&tool=pmcentrez&rendertype=abstract
- Borbély AA, Daan S, Wirz-Justice A, et al. The two-process model of sleep regulation: a reappraisal. J Sleep Res [Internet]. 2016;25:131–143. Available from. http://doi.wiley.com/10.1111/jsr.12371
- Brown RE, Basheer R, McKenna JT, et al. Control of sleep and wakefulness. Physiol Rev [Internet]. 2012 cited 2012 Oct 5;92:1087–1187. Available from. http://www.ncbi.nlm.nih.gov/pubmed/22811426
- Murphy PJ, Campbell SS. Nighttime drop in body temperature: a physiological trigger for sleep onset? Sleep [Internet]. 1997;20:505–511. Available from. http://www.ncbi.nlm.nih.gov/pubmed/9322266
- Reiter RJ. Normal patterns of melatonin levels in the pineal gland and body fluids of humans and experimental animals. J Neural Transm Suppl. 1986;21:35–54.
- Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6:97–111.
- American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.
- Judd BG, Sateia MJ. Classification of sleep disorders. Harding SM, editor. UpToDate [Internet]. Waltham, MA: UpToDate; 2017 cited 2017 Feb 7. Available from. https://www.uptodate.com/contents/classification-of-sleep-disorders/print
- Lie JD, Tu KN, Shen DD, et al. Pharmacological treatment of insomnia. P T [Internet]. 2015;40:759–771. Available from. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4634348&tool=pmcentrez&rendertype=abstract
- NIH State-of-the-Science Conference. Statement on manifestations and management of chronic insomnia in adults. NIH Consens Sci Statements. 2005;22:1–30.
- Bonnet MH, Arand DL. Treatment of insomnia. In: Benca RM, editor. UpToDate [Internet]. Waltham, MA: UpToDate; 2017 [cited 2017 Jan 1]. Available from. https://www.uptodate.com/contents/treatment-of-insomnia
- Kuhn E, Weiss BJ, Taylor KL, et al. CBT-I coach: A description and clinician perceptions of a mobile app for cognitive behavioral therapy for insomnia. J Clin Sleep Med. 2016;12:597–606.
- Buysse DJ. Insomnia. JAMA [Internet]. 2013;309:706–716. Available from. http://www.ncbi.nlm.nih.gov/pubmed/23423416
- Karsten J, Hagenauw LA, Kamphuis J, et al. Low doses of mirtazapine or quetiapine for transient insomnia: a randomised, double-blind, cross-over, placebo-controlled trial. J Psychopharmacol [Internet]. 2017; 26988111668139. Available from. http://journals.sagepub.com/doi/10.1177/0269881116681399
- Riemann D, Spiegelhalder K, Feige B, et al. The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev [Internet]. 2010 cited 2013 Aug 2;14:19–31. Available from. http://www.ncbi.nlm.nih.gov/pubmed/19481481
- Licata SC, Rowlett JK. Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond. Pharmacol Biochem Behav. 2008;90:74–89.
- Davies M. The role of GABAA receptors in mediating the effects of alcohol in the central nervous system. J Psychiatry Neurosci [Internet]. 2003;28:263–274. Available from. http://www.ncbi.nlm.nih.gov/pubmed/12921221%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC165791
- Wang F, Li J, Wu C, et al. The GABAA receptor mediates the hypnotic activity of melatonin in rats. Pharmacol Biochem Behav. 2003;74:573–578.
- Weber J, Siddiqui MAA, Wagstaff AJ, et al. Low-dose doxepin: in the treatment of insomnia. CNS Drugs [Internet]. 2010;24:713–720. Available from. http://www.ncbi.nlm.nih.gov/pubmed/20658801
- Schwartz TL, Goradia V. Managing insomnia: an overview of insomnia and pharmacologic treatment strategies in use and on the horizon. Drugs Context. 2013;2013:212257. doi: 10.7573/dic.212257. eCollection 2013 Oct 4.
- Staner L. Comorbidity of insomnia and depression. Sleep Med Rev [Internet]. 2010;14:35–46. Available from. DOI:10.1016/j.smrv.2009.09.003
- Cardinali DP, Golombek DA, Rosenstein RE, et al. Assessing the efficacy of melatonin to curtail benzodiazepine/Z drug abuse. Pharmacol Res [Internet]. 2016;109:12–23. Available from. DOI:10.1016/j.phrs.2015.08.016
- Schenck CH, Bassetti CL, Arnulf I, et al. English translations of the first clinical reports on narcolepsy and cataplexy by Westphal and Gélineau in the late 19th century, with commentary. J Clin Sleep Med [Internet]. 2007;3:301–311. Available from. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2564780&tool=pmcentrez&rendertype=abstract
- Krahn LE, Lymp JF, Moore WR, et al. Characterizing the emotions that trigger cataplexy. J Neuropsychiatry Clin Neurosci [Internet]. 2005 cited 2012 Feb 24;17:45–50. Available from. http://neuro.psychiatryonline.org/article.aspx?articleid=101935
- Okun ML, Lin L, Pelin Z, et al. Clinical aspects of narcolepsy-cataplexy across ethnic groups. Sleep [Internet]. 2002;25:27–35. Available from. http://www.ncbi.nlm.nih.gov/pubmed/11833858
- Lin L, Faraco J, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell [Internet]. 1999;98:365–376. Available from. http://www.ncbi.nlm.nih.gov/pubmed/10458611
- Nellore A, Randall TD. Narcolepsy and influenza vaccination—the inappropriate awakening of immunity. Ann Transl Med [Internet]. 2016;4:S29–S29. Available from. http://atm.amegroups.com/article/view/12221/12724
- Barateau L, Lopez R, Dauvilliers Y. Management of narcolepsy. Curr Treat Options Neurol. 2016;18:1–13.
- Syed YY. Pitolisant: first global approval. Drugs [Internet]. 2016;76:1313–1318. Available from. http://link.springer.com/10.1007/s40265-016-0620-1
- De La Herrán-Arita AK, Equihua-Benítez AC, Drucker-Colín R. Treatment of cataplexy. Expert Opin Orphan Drugs [Internet]. 2013 [cited 2013 May 28];1:199–210. Available from. http://informahealthcare.com/doi/abs/10.1517/21678707.2013.765359
- Scammell TE. Treatment of narcolepsy in adults. In: Benca RM, editor. UpToDate. Waltham, MA: UpToDate; 2017. Available from: https://www.uptodate.com/contents/treatment-of-narcolepsy-in-adults.
- Hublin C, Partinen M, Heinonen E, et al. Selegiline in the treatment of narcolepsy. Neurology. 1994;44:2095–2101.
- Nittur N, Konofal E, Dauvilliers Y, et al. Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review. Sleep Med [Internet]. 2013;14:30–36. Available from. DOI:10.1016/j.sleep.2012.07.008
- Vaughan GM, Allen JP, Tullis W, et al. Overnight plasma profiles of melatonin and certain adenohypophyseal hormones in men*. J Clin Endocrinol Metab [Internet]. 1978;47:566–571. Available from. https://academic.oup.com/jcem/article-lookup/doi/10.1210/jcem-47-3-566
- Bartness TJ, Powers JB, Hastings MH, et al. The timed infusion paradigm for melatonin delivery: what has it taught us about the melatonin signal, its reception, and the photoperiodic control of seasonal responses? J Pineal Res [Internet]. 1993;15:161–190. Available from. http://www.ncbi.nlm.nih.gov/pubmed/8120796
- Cajochen C, Kräuchi K, Wirz-Justice A, et al. Role of melatonin in the regulation of human circadian rhythms and sleep. J Neuroendocrinol [Internet]. 2003;15:432–437. Available from. http://www.ncbi.nlm.nih.gov/pubmed/12622846
- Parry BL. Jet lag: minimizing it’s effects with critically timed bright light and melatonin administration. J Mol Microbiol Biotechnol [Internet]. 2002;4:463–466. Available from. http://www.ncbi.nlm.nih.gov/pubmed/12432956
- Kuriyama A, Honda M, Hayashino Y. Ramelteon for the treatment of insomnia in adults: A systematic review and meta-analysis. Sleep Med [Internet]. 2014;15:385–392. Available from. DOI:10.1016/j.sleep.2013.11.788
- Pandi-Perumal SR, Spence DW, Verster JC, et al. Pharmacotherapy of insomnia with ramelteon: safety, efficacy and clinical applications. J Cent Nerv Syst Dis [Internet]. 2011 cited 2013 Aug 7;3:51–65. Available from. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3663615&tool=pmcentrez&rendertype=abstract
- Uchiyama M, Hamamura M, Kuwano T, et al. Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomnia. Sleep Med [Internet]. 2011;12:127–133. Available from. DOI:10.1016/j.sleep.2010.10.006
- Thakkar MM. Histamine in the regulation of wakefulness. Sleep Med Rev [Internet]. 2011;15:65–74. Available from. DOI:10.1016/j.smrv.2010.06.004
- Kalivas P. Histamine-induced arousal in the conscious and pentobarbital-pretreated rat. 1982;222:37–42.
- Huang Z-L, Mochizuki T, Qu W-M, et al. Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice. Proc Natl Acad Sci U S A [Internet]. 2006;103:4687–4692. Available from. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1450232&tool=pmcentrez&rendertype=abstract
- Monti JM, Pellejero T, Jantos H. Effects of H1- and H2-histamine receptor agonists and antagonists on sleep and wakefulness in the rat. J Neural Transm [Internet]. 1986;66:1–11. Available from. http://www.ncbi.nlm.nih.gov/pubmed/3734773
- Lin JS, Sakai K, Vanni-Mercier G, et al. Involvement of histaminergic neurons in arousal mechanisms demonstrated with H3-receptor ligands in the cat. Brain Res. 1990;523:325–330.
- Schneider EH, Seifert R. The histamine H4-receptor and the central and peripheral nervous system: a critical analysis of the literature. Neuropharmacology [Internet]. 2016;106:116–128. Available from. DOI:10.1016/j.neuropharm.2015.05.004
- Wang Y-Q-Q, Takata Y, Li R, et al. Doxepin and diphenhydramine increased non-rapid eye movement sleep through blockade of histamine H1 receptors. Pharmacol Biochem Behav [Internet]. 2015;129:56–64. Available from. DOI:10.1016/j.pbb.2014.12.002
- Dauvilliers Y, Bassetti C, Lammers GJ, et al. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Lancet Neurol [Internet]. 2013;12:1068–1075. Available from. http://www.ncbi.nlm.nih.gov/pubmed/24107292
- Szakacs Z, Dauvilliers Y, Mikhaylov V, et al. Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial. Lancet Neurol [Internet]. 2017. Available from. http://www.ncbi.nlm.nih.gov/pubmed/28129985
- John J, Wu M, Boehmer LN, et al. Cataplexy-active neurons in the hypothalamus : implications for the role of histamine in sleep and waking behavior. Neuron. 2004;42:619–634.
- Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell [Internet]. 1998;92:573–585. Available from. http://www.ncbi.nlm.nih.gov/pubmed/9491897
- Hara J, Beuckmann CT, Nambu T, et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity southwestern medical center at Dallas. Neuron. 2001;30:345–354.
- Willie JT, Takahira H, Shibahara M, et al. Ectopic overexpression of orexin alters sleep/wakefulness states and muscle tone regulation during REM sleep in mice. J Mol Neurosci [Internet]. 2011 cited 2013 Aug 21;43:155–161. Available from. http://www.ncbi.nlm.nih.gov/pubmed/20711757
- Prober DA, Rihel J, Onah AA, et al. Hypocretin/orexin overexpression induces an insomnia-like phenotype in zebrafish. J Neurosci [Internet]. 2006 cited 2013 Aug 15;26:13400–13410. Available from. http://www.ncbi.nlm.nih.gov/pubmed/17182791
- Coleman PJ, Gotter AL, Herring WJ, et al. The discovery of suvorexant, the first orexin receptor drug for insomnia. Annu Rev Pharmacol Toxicol [Internet]. 2017;57:annurev-pharmtox-010716-104837. Available from. http://www.annualreviews.org/doi/10.1146/annurev-pharmtox-010716-104837
- Herring WJ, Snyder E, Budd K, et al. Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. Neurology [Internet]. 2012 cited 2013 Aug 23;79:2265–2274. Available from. http://www.ncbi.nlm.nih.gov/pubmed/23197752
- Dimova H. Clinical Pharmacology/Biopharmaceutics Review Suvorexant (MK-4305). MD: Silver Spring; 2013.
- Moore TJ, Cohen MR, Furberg CD, et al. New safety perspectives. Quart Watch. 2016;429:1–20.
- Kripke DF. Is suvorexant a better choice than alternative hypnotics? F1000Research. 2015;4:456.
- Mieda M, Hasegawa E, Kisanuki YY, et al. Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep. J Neurosci [Internet]. 2011 cited 2013 Aug 7;31:6518–6526. Available from. http://www.ncbi.nlm.nih.gov/pubmed/21525292
- Equihua AC, De La Herrán-Arita AK, Drucker-Colin R. Orexin receptor antagonists as therapeutic agents for insomnia. Front Pharmacol [Internet]. 2013 [cited 2014 Sep 25];4:163. Available from. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3872321&tool=pmcentrez&rendertype=abstract
- Bonaventure P, Shelton J, Yun S, et al. Characterization of JNJ-42847922, a selective orexin-2 receptor antagonist, as a clinical candidate for the treatment of insomnia. J Pharmacol Exp Ther. 2015;354:471–482.
- Mieda M, Willie JT, Hara J, et al. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci U S A [Internet]. 2004;101:4649–4654. Available from. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=384801&tool=pmcentrez&rendertype=abstract
- Nagahara T, Saitoh T, Kutsumura N, et al. Design and synthesis of non-peptide, selective orexin receptor 2 agonists. J Med Chem. 2015;58:7931–7937.
- Turku A, Borrel A, Leino TO, et al. Pharmacophore model to discover OX 1 and OX 2 orexin receptor ligands. J Med Chem [Internet]. 2016;59:8263–8275. Available from. http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b00333
- Willie JT, Chemelli RM, Sinton CM, et al. Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice. Neuron [Internet]. 2003 cited 2013 Sep 4];38:715–730. Available from. http://linkinghub.elsevier.com/retrieve/pii/S0896627303003301
- Broberger C, De Lecea L, Sutcliffe JG, et al. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol. 1998;402:460–474.
- Saito Y, Nagasaki H. The melanin-concentrating hormone system and its physiological functions. Results Probl Cell Differ. 2008;46:159–179.
- Gao X-B. van den Pol AN. Melanin-concentrating hormone depresses synaptic activity of glutamate and GABA neurons from rat lateral hypothalamus. J Physiol. 2001;533:237–252.
- Hassani OK, Lee MG, Jones BE. Melanin-concentrating hormone neurons discharge in a reciprocal manner to orexin neurons across the sleep-wake cycle. Proc Natl Acad Sci [Internet]. 2009;106:2418–2422. Available from. http://www.ncbi.nlm.nih.gov/pubmed/19188611%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC2650171
- Tan C, Sano H, Iwaasa H, et al. Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expression. Genomics. 2002;79:785–792.
- Qu D, Ludwig DS, Gammeltoft S, et al. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature. 1996;380:243–247.
- Borowsky B, Durkin MM, Ogozalek K, et al. Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat Med. 2002;8:825–830.
- Blanco-Centurion C, Liu M, Konadhode RP, et al. Optogenetic activation of melanin-concentrating hormone neurons increases non-rapid eye movement and rapid eye movement sleep during the night in rats. Eur J Neurosci. 2016;44:2846–2857.
- Tsunematsu T, Kilduff TS, Boyden ES, et al. Acute optogenetic silencing of orexin/hypocretin neurons induces slow-wave sleep in mice. J Neurosci [Internet]. 2011 cited 2012 Oct 11;31:10529–10539. Available from. http://www.ncbi.nlm.nih.gov/pubmed/21775598
- Ahnaou A, Drinkenburg WHIM, Bouwknecht JA, et al. Blocking melanin-concentrating hormone MCH1 receptor affects rat sleep–wake architecture. Eur J Pharmacol [Internet]. 2008;579:177–188. Available from. http://linkinghub.elsevier.com/retrieve/pii/S0014299907011314
- MacNeil DJ, Bednarek MA. MCH receptor peptide agonists and antagonists. Peptides. 2009;30:2008–2013.
- Chen X, Mihalic J, Fan P, et al. Discovery and characterization of a potent and selective antagonist of melanin-concentrating hormone receptor 2. Bioorg Med Chem Lett [Internet]. 2012;22:363–366. Available from. http://www.sciencedirect.com/science/article/pii/S0960894X11015320
- Kawata Y, Okuda S, Hotta N, et al. A novel and selective melanin-concentrating hormone receptor 1 antagonist ameliorates obesity and hepatic steatosis in diet-induced obese rodent models. Eur J Pharmacol [Internet]. 2017;796:45–53. Available from. http://linkinghub.elsevier.com/retrieve/pii/S0014299916307877